GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease[1].
Molecular Weight:
518.58
Purity:
98.15
CAS Number:
[801312-28-7]
Formula:
C27H26N4O5S
Target:
Phosphodiesterase (PDE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted